Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04556201 · ClinicalTrials.gov registry record · NA
The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones
A NA study, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT04556201 is a NA study that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 450 participants.
The verdict
NCT04556201, a NA study, has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
The purpose of this study is to collect real-world evidence on the performance of the SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.
Interventions
- DEVICE SOLTIVE™ Premium SuperPulsed Laser Fiber System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04556201
The ClinicalTrials.gov registry entry for NCT04556201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SOLTIVE™ Premium SuperPulsed Laser Fiber System is the first listed.
NCT04556201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04556201 about?
NCT04556201 is a clinical study titled "The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones". The purpose of this study is to collect real-world evidence on the performance of the SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.
What is the current status of trial NCT04556201?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2020-12-01. Estimated completion is 2023-05-30.
What interventions are being tested in trial NCT04556201?
The interventions under investigation include: SOLTIVE™ Premium SuperPulsed Laser Fiber System (DEVICE).
Who is sponsoring clinical trial NCT04556201?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.